Gabapentin and Vabysmo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Vabysmo (faricimab-svoa). Common drug interactions include endophthalmitis among females and ill-defined disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Vabysmo. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Vabysmo?

Vabysmo has active ingredients of faricimab-svoa. eHealthMe is studying from 1,425 Vabysmo users. Check the latest studies of Vabysmo.

On Jul, 26, 2026

17 people who take Gabapentin and Vabysmo together, and have interactions are studied.

Gabapentin and Vabysmo drug interactions.

What are the common drug interactions of Gabapentin and Vabysmo, by gender? *:

female:

Endophthalmitis (inflammation of the internal coats of the eye)
Eye pain
Blood glucose increased
Thirst
Vitreous floaters (spots before the eyes)
Eye infection
Fatigue (feeling of tiredness)
Gait disturbance
Neoplasm progression (growth of tumour)
Retinal artery occlusion (blockage of retinal artery)

male:

Ill-defined disorder
Iridocyclitis (inflammation of the iris and ciliary body of the eye)
Hypertension (high blood pressure)
Rash
Varicose vein (veins that have become enlarged and tortuous)
Eye pain
Lung neoplasm malignant (cancer tumour of lung)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nasopharyngitis (inflammation of the nasopharynx)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)

What are the common drug interactions of Gabapentin and Vabysmo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Eye pain
Blood glucose increased
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Vision blurred
Fatigue (feeling of tiredness)
Neoplasm progression (growth of tumour)
Retinal artery occlusion (blockage of retinal artery)
Visual impairment
Vitreous floaters (spots before the eyes)
Ill-defined disorder

What are the existing conditions these people have? *

Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 5 people, 29.41%
Neuropathy Peripheral (surface nerve damage): 4 people, 23.53%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 17.65%
High Blood Pressure: 3 people, 17.65%
High Blood Cholesterol: 2 people, 11.76%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 11.76%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.76%
Back Pain: 2 people, 11.76%
Inflammation: 2 people, 11.76%
Erection Problems: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Vabysmo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously